Literature DB >> 4013745

Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls.

B Christensson, S A Hedström.   

Abstract

The prevalence of antibodies to Toxic Shock Syndrome Toxin (TSST-1) in a Swedish healthy control population was investigated using an enzyme-linked immunosorbent assay (ELISA). 88% of the control group above the age of 10 showed positive antibody levels as compared to 31% of those who were under 10 years old. These results indicate a very common normal exposure to TSST-1 during early life and also identify the small risk-group of potential TSS-patients. Patients with S. aureus endocarditis and septicemia showed slightly higher antibody levels as compared to the controls (p less than 0.05). The difference was in part due to 3/4 septicemia patients, infected with TSST-1 producing strains, who showed very high antibody levels. None of these 4 patients developed any signs of TSS. 5/5 menstrual associated TSS-patients were negative in the ELISA in serial serum samples as were 3/5 non-menstrual associated TSS-patients. The TSST-1 ELISA is proposed for identifying chiefly young women at risk of acquiring menstrual related Toxic Shock Syndrome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4013745     DOI: 10.1111/j.1699-0463.1985.tb02857.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  12 in total

1.  Immune modulation with a staphylococcal preparation in fibromyalgia/chronic fatigue syndrome: relation between antibody levels and clinical improvement.

Authors:  O Zachrisson; P Colque-Navarro; C G Gottfries; B Regland; R Möllby
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-20       Impact factor: 3.267

2.  [IgM antibodies to toxic shock syndrome toxin-1 in human sera and human immunoglobulins].

Authors:  N Dickgiesser; F Düzgün
Journal:  Klin Wochenschr       Date:  1988-01-04

3.  Antibody responses in patients with staphylococcal septicemia against two Staphylococcus aureus fibrinogen binding proteins: clumping factor and an extracellular fibrinogen binding protein.

Authors:  P Colque-Navarro; M Palma; B Söderquist; J I Flock; R Möllby
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Imbalanced serum IgG subclass pattern in toxic shock syndrome patients: deficiency of specific IgG1 and IgG4 subclass antibodies to toxic shock syndrome toxin 1.

Authors:  B Christensson; P J Johansson; V A Oxelius
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

5.  [IgG antibodies to toxic shock syndrome toxin-1 (TSST-1) in human sera].

Authors:  N Dickgiesser; B Kustermann
Journal:  Klin Wochenschr       Date:  1987-03-16

Review 6.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

7.  Production of antibodies to staphylococcal superantigens in atopic dermatitis.

Authors:  D E Campbell; A S Kemp
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 8.  Will there ever be a universal Staphylococcus aureus vaccine?

Authors:  Gerald B Pier
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

9.  The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.

Authors:  Jacob D Pierson; Melanie A Hansmann; Catherine C Davis; Larry J Forney
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

10.  Infection with Staphylococcus aureus producing toxic shock syndrome (TSS) toxin-1 without TSS.

Authors:  D Nadal; U A Hunziker; U Bauersfeld; H Pfister; W H Hitzig
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.